By. Ruth O’Regan MD Date: 12/07/2023In an interview, Ruth O’Regan MD addresses questions related to the…

Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…

At ASH 2023, Katherine Broome, MD, a medical doctor and medical oncologist at the Georgetown…

Evandro Bezerra, MD, hematologist and assistant professor at The Ohio State University Wexner Medical Center,…

At ASH 2023, Ola Landgren, MD, Professor of Medicine and Chief Division of Myeloma at…

Rabi Hanna, MD, from the Department of Pediatric Hematology Oncology and BMT at Cleveland Clinic…

Allen Wilbanks stands at the forefront of SABCS 2023, the setting for a conversation with…

By. Valeria Santini, MDDate: 12/13/2023At the ASH 2023 symposium, Valeria Santini, MD, a distinguished medical…

Allen Wilbanks stood alongside Alina Hamilton, PhD, at the SABCS 2023 event, where they delved…

By. Neil Carleton, MD Date. 12/07/2023 In the interview with Neil Carleton, MD, the discussion revolved…